Christina D. Drenberg
Publications by Year
Research Areas
Epigenetics and DNA Methylation, PARP inhibition in cancer therapy, Acute Myeloid Leukemia Research, Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors
Most-Cited Works
- → The genomic landscape of hypodiploid acute lymphoblastic leukemia(2013)717 cited
- → Combined Targeting of JAK2 and Bcl-2/Bcl-xL to Cure Mutant JAK2-Driven Malignancies and Overcome Acquired Resistance to JAK2 Inhibitors(2013)132 cited
- → Panobinostat Enhances Cytarabine and Daunorubicin Sensitivities in AML Cells through Suppressing the Expression of BRCA1, CHK1, and Rad51(2013)93 cited
- → Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response(2018)66 cited
- → OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues(2017)57 cited
- → Evaluation of artemisinins for the treatment of acute myeloid leukemia(2016)50 cited
- → A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML(2019)41 cited
- → Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia(2017)38 cited
- → Urinary angiostatin levels are elevated in patients with epithelial ovarian cancer(2010)21 cited
- → Pharmacological Characterization of JNJ-75276617, a Menin-KMT2A Inhibitor, As Targeted Treatment for KMT2A-Altered and NPM1-Mutant Acute Leukemia(2022)16 cited